Structure-based design of potent HIV-1 protease inhibitors with modified P1-biphenyl ligands: synthesis, biological evaluation, and enzyme-inhibitor X-ray structural studies

J Med Chem. 2015 Jul 9;58(13):5334-43. doi: 10.1021/acs.jmedchem.5b00676. Epub 2015 Jun 24.

Abstract

We report the design, synthesis, X-ray structural studies, and biological evaluation of a novel series of HIV-1 protease inhibitors. We designed a variety of functionalized biphenyl derivatives to make enhanced van der Waals interactions in the S1 subsite of HIV-1 protease. These biphenyl derivatives were conveniently synthesized using a Suzuki-Miyaura cross-coupling reaction as the key step. We examined the potential of these functionalized biphenyl-derived P1 ligands in combination with 3-(S)-tetrahydrofuranyl urethane and bis-tetrahydrofuranyl urethane as the P2 ligands. Inhibitor 21e, with a 2-methoxy-1,1'-biphenyl derivative as P1 ligand and bis-THF as the P2 ligand, displayed the most potent enzyme inhibitory and antiviral activity. This inhibitor also exhibited potent activity against a panel of multidrug-resistant HIV-1 variants. A high resolution X-ray crystal structure of related Boc-derivative 17a-bound HIV-1 protease provided important molecular insight into the ligand-binding site interactions of the biphenyl core in the S1 subsite of HIV-1 protease.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Binding Sites
  • Biphenyl Compounds / chemistry*
  • Carbamates / chemistry*
  • Carbamates / pharmacology*
  • Crystallography, X-Ray
  • Drug Design*
  • HIV Protease / chemistry*
  • HIV Protease / metabolism
  • HIV Protease Inhibitors / chemistry*
  • HIV Protease Inhibitors / pharmacology*
  • HIV-1 / drug effects*
  • Humans
  • Ligands
  • Models, Molecular
  • Molecular Dynamics Simulation
  • Molecular Structure
  • Protein Conformation
  • Stereoisomerism
  • Structure-Activity Relationship
  • Sulfonamides / chemistry*
  • Sulfonamides / pharmacology*
  • Urethane / chemistry

Substances

  • Biphenyl Compounds
  • Carbamates
  • HIV Protease Inhibitors
  • Ligands
  • Sulfonamides
  • hexahydrofuro(2,3-b)furan-3-yl-(3-hydroxy-4-(N-isobutyl-4-methoxyphenylsulfonamido)-1-(2'-methoxy-(1,1'-biphenyl)-3-yl)butan-2-yl)carbamate
  • diphenyl
  • Urethane
  • HIV Protease
  • p16 protease, Human immunodeficiency virus 1